{"id":"https://openalex.org/W1574620176","doi":"https://doi.org/10.1111/j.1365-2141.2010.08425.x","title":"Mitoxantrone in combination with an inhibitor of DNA\u2010dependent protein kinase: a potential therapy for high risk B\u2010cell chronic lymphocytic leukaemia","display_name":"Mitoxantrone in combination with an inhibitor of DNA\u2010dependent protein kinase: a potential therapy for high risk B\u2010cell chronic lymphocytic leukaemia","publication_year":2010,"publication_date":"2010-11-18","ids":{"openalex":"https://openalex.org/W1574620176","doi":"https://doi.org/10.1111/j.1365-2141.2010.08425.x","mag":"1574620176","pmid":"https://pubmed.ncbi.nlm.nih.gov/21083655"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2010.08425.x","doi":"https://doi.org/10.1111/j.1365-2141.2010.08425.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2010.08425.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111803163","display_name":"Sarah L. Elliott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah L. Elliott","raw_affiliation_strings":["Newcastle Cancer Centre at the NorthernInstitute for Cancer Research, Medical School, Newcastle University, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle Cancer Centre at the NorthernInstitute for Cancer Research, Medical School, Newcastle University, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070928346","display_name":"Clark Crawford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Clark Crawford","raw_affiliation_strings":["The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015442135","display_name":"Evan A. Mulligan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Evan Mulligan","raw_affiliation_strings":["The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Geoffrey Summerfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108554","display_name":"Queen Elizabeth Hospital","ror":"https://ror.org/015dyrs73","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210103856","https://openalex.org/I4210108554"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Geoffrey Summerfield","raw_affiliation_strings":["Queen Elizabeth Hospital, Gateshead"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth Hospital, Gateshead","institution_ids":["https://openalex.org/I4210108554"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027144028","display_name":"Paula Newton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120890","display_name":"Sunderland Royal Hospital","ror":"https://ror.org/02s0dm484","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210120890","https://openalex.org/I4210135167"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula Newton","raw_affiliation_strings":["Sunderland Royal Hospital, Sunderland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunderland Royal Hospital, Sunderland","institution_ids":["https://openalex.org/I4210120890"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110104423","display_name":"Jonathan Peter Wallis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801924861","display_name":"Freeman Hospital","ror":"https://ror.org/00cdwy346","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801663869","https://openalex.org/I2801924861"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Wallis","raw_affiliation_strings":["Freeman Hospital, Newcastle upon Tyne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Freeman Hospital, Newcastle upon Tyne","institution_ids":["https://openalex.org/I2801924861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054512638","display_name":"Tryfonia Mainou\u2010Fowler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tryfonia Mainou\u2010Fowler","raw_affiliation_strings":["The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004618702","display_name":"Paul Evans","orcid":"https://orcid.org/0000-0002-7915-0946","observed_orcids":["https://orcid.org/0000-0002-7915-0946"]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Evans","raw_affiliation_strings":["St James University Hospital, Leeds"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St James University Hospital, Leeds","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012658427","display_name":"Clare Bedwell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801663869","display_name":"Newcastle upon Tyne Hospitals NHS Foundation Trust","ror":"https://ror.org/05p40t847","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Clare Bedwell","raw_affiliation_strings":["Northern Genetics Service, Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Genetics Service, Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2801663869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113573214","display_name":"Barbara W. Durkacz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Barbara W. Durkacz","raw_affiliation_strings":["The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025823276","display_name":"Elaine Willmore","orcid":"https://orcid.org/0000-0002-4762-094X","observed_orcids":["https://orcid.org/0000-0002-4762-094X"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Elaine Willmore","raw_affiliation_strings":["The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne","institution_ids":["https://openalex.org/I84884186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5025823276"],"corresponding_institution_ids":["https://openalex.org/I84884186"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.565,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.81868553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"152","issue":"1","first_page":"61","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9330000281333923},{"id":"https://openalex.org/keywords/dna-dependent-protein-kinase","display_name":"DNA-dependent protein kinase","score":0.9269999861717224},{"id":"https://openalex.org/keywords/nu7441","display_name":"NU7441","score":0.9890000224113464},{"id":"https://openalex.org/keywords/b-cell-chronic-lymphocytic-leukaemia","display_name":"B-cell chronic lymphocytic leukaemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.8029999732971191},{"id":"https://openalex.org/keywords/del-13q","display_name":"del(13q)","score":0.8550000190734863},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8820000290870667},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6869999766349792},{"id":"https://openalex.org/keywords/ku80","display_name":"Ku80","score":0.765999972820282},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8930000066757202},{"id":"https://openalex.org/keywords/topoisomerase-ii-beta","display_name":"topoisomerase II beta","score":0.9739999771118164},{"id":"https://openalex.org/keywords/prkdc","display_name":"PRKDC","score":0.984000027179718},{"id":"https://openalex.org/keywords/gamma-h2ax-foci","display_name":"\u03b3H2AX foci","score":0.8220000267028809},{"id":"https://openalex.org/keywords/drug-sensitization","display_name":"drug sensitization","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.8224285840988159},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.611389696598053},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.6024346351623535},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5672714114189148},{"id":"https://openalex.org/C68748289","wikidata":"https://www.wikidata.org/wiki/Q18030783","display_name":"DNA-PKcs","level":4,"score":0.52695232629776},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5057275295257568},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49991393089294434},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.474413126707077},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.45736369490623474},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.43637293577194214},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.42492949962615967},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.42434513568878174},{"id":"https://openalex.org/C150109051","wikidata":"https://www.wikidata.org/wiki/Q3630494","display_name":"Autophosphorylation","level":4,"score":0.420998215675354},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.30751579999923706},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.284595251083374},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28096210956573486},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2493172585964203},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.244558185338974},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1531398594379425},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14064231514930725},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12209165096282959},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10936254262924194}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004260","descriptor_name":"DNA Repair","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017077","descriptor_name":"Culture Media, Conditioned","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051747","descriptor_name":"DNA-Activated Protein Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051747","descriptor_name":"DNA-Activated Protein Kinase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051747","descriptor_name":"DNA-Activated Protein Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2141.2010.08425.x","doi":"https://doi.org/10.1111/j.1365-2141.2010.08425.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2010.08425.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:21083655","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21083655","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7699999809265137,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320215","display_name":"Leukaemia and Lymphoma Research","ror":"https://ror.org/0055acf80"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W87583817","https://openalex.org/W1982945504","https://openalex.org/W1990826225","https://openalex.org/W1991332313","https://openalex.org/W2009593167","https://openalex.org/W2012324369","https://openalex.org/W2024254896","https://openalex.org/W2029389235","https://openalex.org/W2033484193","https://openalex.org/W2043510752","https://openalex.org/W2077982832","https://openalex.org/W2091279703","https://openalex.org/W2094532656","https://openalex.org/W2096036897","https://openalex.org/W2097517187","https://openalex.org/W2097852595","https://openalex.org/W2099645964","https://openalex.org/W2100121711","https://openalex.org/W2105762637","https://openalex.org/W2107334098","https://openalex.org/W2126796352","https://openalex.org/W2130266193","https://openalex.org/W2143340316","https://openalex.org/W2156063202","https://openalex.org/W2161911433","https://openalex.org/W2162441777","https://openalex.org/W2297718137","https://openalex.org/W2416220740","https://openalex.org/W2586663048"],"related_works":["https://openalex.org/W7221016964","https://openalex.org/W1633211318","https://openalex.org/W2105762637","https://openalex.org/W2562333758","https://openalex.org/W2296075089","https://openalex.org/W2557557393","https://openalex.org/W1806120780","https://openalex.org/W2398240122","https://openalex.org/W2139820303","https://openalex.org/W7095068679"],"abstract_inverted_index":{"Defects":[0],"in":[1,67,90,132,168,194],"the":[2,57,120,186],"DNA":[3,136],"damage":[4],"response":[5],"pathway":[6],"[e.g.":[7],"del(17p)]":[8],"are":[9],"associated":[10],"with":[11,29,79,155,175],"drug-resistant":[12],"B-cell":[13],"chronic":[14],"lymphocytic":[15],"leukaemia":[16],"(CLL).":[17],"We":[18],"previously":[19],"demonstrated":[20],"that":[21,32,50,129],"over-expression":[22],"of":[23,34,45,59,87,119,134,158,188],"DNA-dependent":[24],"protein":[25,177],"kinase":[26],"(DNA-PK)":[27],"correlates":[28],"chemo-resistance":[30],"and":[31,47,55,108,162],"inhibition":[33],"DNA-PK":[35,46,61,121,130,189],"sensitizes":[36],"CLL":[37,68,75,88],"cells":[38,72,89],"to":[39,77,84,143],"chemotherapeutics.":[40],"Here,":[41],"we":[42],"investigated":[43],"expression":[44],"other":[48],"proteins":[49],"impact":[51],"on":[52,64],"drug":[53],"resistance,":[54],"evaluated":[56],"effects":[58],"a":[60,191],"inhibitor":[62],"(NU7441)":[63],"mitoxantrone-induced":[65,117,135],"cytotoxicity":[66],"cells.":[69],"NU7441":[70,109,115],"sensitized":[71],"from":[73,82],"42/49":[74],"samples":[76],"mitoxantrone,":[78],"sensitization":[80,100],"ranging":[81],"2-":[83],"200-fold":[85],"Co-culture":[86],"conditioned":[91],"stromal":[92],"medium":[93],"increased":[94,110],"chemoresistance":[95],"but":[96,148],"did":[97],"not":[98],"reduce":[99],"by":[101,153],"NU7441.":[102,156],"Mitoxantrone":[103],"treatment":[104],"induced":[105],"\u03b3H2AX":[106],"foci":[107],"their":[111],"longevity":[112],"(24":[113],"h).":[114],"prevented":[116],"autophosphorylation":[118],"catalytic":[122],"subunit":[123],"(DNA-PKcs)":[124],"at":[125],"Ser":[126],"2056,":[127],"confirming":[128],"participates":[131],"repair":[133],"damage.":[137],"del(17p)":[138,169],"cases":[139],"were":[140,149,165],"more":[141],"resistant":[142],"mitoxantrone":[144],"than":[145],"del(13q)":[146],"cases,":[147],"resensitized":[150],"(7-16":[151],"fold)":[152],"co-incubation":[154],"Expression":[157],"DNA-PKcs,":[159],"Ku80,":[160],"P-glycoprotein":[161],"topoisomerase":[163],"II\u03b2":[164],"significantly":[166],"higher":[167],"cases.":[170],"PRKDC":[171],"mRNA":[172],"levels":[173],"correlated":[174],"DNA-PKcs":[176],"expression,":[178],"which":[179],"predicted":[180],"shorter":[181],"survival.":[182],"These":[183],"data":[184],"confirm":[185],"potential":[187],"as":[190],"therapeutic":[192],"target":[193],"poor":[195],"prognosis":[196],"CLL.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}